Medicenna Therapeutics Corp (TSE:MDNA)
TSX:MDNA
Holding TSE:MDNA?
Track your performance easily

Medicenna Therapeutics Corp (MDNA) Cash flow

178 Followers

Medicenna Therapeutics Corp Cash Flow

TSE:MDNA's free cash flow for Q1 2025 was C$-2.36M. For the 2025 fiscal year, TSE:MDNA's free cash flow was decreased by C$-16.26M and operating cash flow was C$-2.33M. See a summary of the company’s cash flow.
Cash Flow
TTM
Mar 24Mar 23Mar 22Mar 21Mar 20
Operating Cash Flow
C$ -15.12MC$ -16.26MC$ -12.66MC$ -23.58MC$ -15.31MC$ -5.42M
Investing Cash Flow
C$ -31.00K--C$ 10.05MC$ 5.01MC$ -15.00M
Financing Cash Flow
C$ 20.90M-C$ 24.76MC$ 3.47MC$ 18.26MC$ 40.74M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
C$ 100.06MC$ 16.98MC$ 33.60MC$ 20.13MC$ 30.38MC$ 22.70M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
------
Issuance Of Capital Stock
--C$ 848.00KC$ 3.51MC$ 11.41MC$ 38.38M
Issuance Of Debt
---C$ -37.00KC$ -39.00K-
Repayment Of Debt
---C$ -37.00KC$ -39.00KC$ -3.00K
Free Cash Flow
C$ -11.13MC$ -16.26M-C$ -23.58MC$ -15.31MC$ -5.42M
Domestic Sales
------
Foreign Sales
------
Currency in CAD

Medicenna Therapeutics Corp Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis